Monday, May 11, 2009

Proteotech Nabs $500K In Debt Funding

Kirkland, Washington-based Proteotech has scored $519,401 in debt financing, according to a recent regulatory filing by the firm. Source of the debt financing was not disclosed. Proteotech develops treatments for Alzheimer's disease, Parkinson's disease, type 2 diabetes and systemic amyloidosis. More information »